Skip to main content

Author: Tom Wilemon

Ciombor chosen for NCI clinical investigator team leadership award

Jul. 15, 2021—Kristen Ciombor, MD, MSCI, is one of 10 physicians nationwide selected by the National Cancer Institute (NCI) for the 2021 Cancer Clinical Investigator Team Leadership Award.

Read more


Susan G. Komen funds VICC breast cancer initiatives

Jul. 15, 2021—Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.

Read more


Davis promoted to Vice President for VUMC Cancer Care Network and Strategy

Jul. 14, 2021—Nancy Davis, MD, has been promoted to Vice President for Cancer Care Network and Strategy at Vanderbilt University Medical Center, a new position responsible for developing provider relationships with other health care systems and expanding access to oncology care throughout Tennessee and other states.

Read more


Preclinical study supports rigosertib as booster to immunotherapy treatment for melanoma

Jul. 1, 2021—A team of Vanderbilt researchers have shown in a preclinical study that the investigational drug rigosertib could be a potential booster treatment to elicit response to immunotherapies among melanoma patients.

Read more


Tuya Pal named Komen Scholar

Jun. 24, 2021—Susan G. Komen announced on June 23 that Tuya Pal, MD, associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Cancer Research, has been named a Komen Scholar.

Read more


Study shows benefit of scheduling lung screens with mammograms

Jun. 23, 2021—Women who are longtime smokers could potentially save their lives by undergoing lung screens on the same day they schedule mammograms, according to a study by Vanderbilt researchers published in the Journal of Medical Screening.

Read more


National Black Family Cancer Awareness Week is call to action

Jun. 9, 2021—National Black Family Cancer Awareness Week, June 17-23, aims to spur conversations followed by actions to make advancements in care more equitable.

Read more


Vanderbilt researchers present new data on clinical trials at ASCO 2021

May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.

Read more


Analysis reveals macrophages associated with kidney cancer recurrence

May. 24, 2021—A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.

Read more


William and Frances Blot deed home to VUMC to benefit cancer patients

May. 20, 2021—Their condominium in The Westbury was at the heart of all that William and Frances Blot loved about Nashville — its proximity to Vanderbilt where he worked for two decades, its sidewalk that led to the greenspaces where they would watch the seasons change, and its residents who became more like friends than neighbors.

Read more


People at high genetic risk for colorectal cancer benefit more from lifestyle changes

May. 13, 2021—People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.

Read more


AACR second session to feature Vanderbilt researchers

May. 12, 2021—The second session of the American Association for Cancer Research (AACR) Annual meeting, May 17-21, features several researchers from Vanderbilt-Ingram Cancer Center.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more